Standout Papers

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind... 2009 2026 2014 2020 916
  1. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study (2009)
    Jedd D. Wolchok, Bart Neyns et al. The Lancet Oncology

Immediate Impact

31 by Nobel laureates 19 from Science/Nature 112 standout
Sub-graph 1 of 19

Citing Papers

Probiotic-guided CAR-T cells for solid tumor targeting
2023 StandoutScience
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
2021 Standout
41 intermediate papers

Works of William Waterfield being referenced

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
2009 Standout
Efficacy of ipilimumab 10 mg/kg in advanced melanoma patients (pts) with good and poor prognostic factors
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
William Waterfield 986 46 494 244 12 1.1k
Prakash Kharel 713 59 333 242 13 978
Jasmine I. Rizzo 1070 46 454 372 17 1.2k
Ramesh Kumar Pandey 671 64 365 205 18 1.0k
Raju Vaddepally 717 67 343 198 10 955
C. Libenciuc 661 38 340 184 7 893
Anne Montfort 728 49 702 290 18 1.2k
H. David Inzunza 788 53 480 224 11 996
Christiane Meyer 926 50 1012 241 8 1.3k
Jing Liu 832 147 566 252 17 1.3k
Alejandra Flores-Chávez 703 112 396 151 14 1.2k

All Works

Loading papers...

Rankless by CCL
2026